Dermatological toxicity of imatinib mesylate.
dc.contributor.author | Prasad, N | en_US |
dc.contributor.author | Deshmukh, C | en_US |
dc.contributor.author | Biswas, G | en_US |
dc.contributor.author | Bakshi, A | en_US |
dc.contributor.author | Sastry, P S R K | en_US |
dc.contributor.author | Parikh, P M | en_US |
dc.date.accessioned | 2005-04-01 | en_US |
dc.date.accessioned | 2009-05-30T17:29:02Z | |
dc.date.available | 2005-04-01 | en_US |
dc.date.available | 2009-05-30T17:29:02Z | |
dc.date.issued | 2005-04-01 | en_US |
dc.description.affiliation | Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, India 400012. | en_US |
dc.identifier.citation | Prasad N, Deshmukh C, Biswas G, Bakshi A, Sastry PS, Parikh PM. Dermatological toxicity of imatinib mesylate. Journal of the Association of Physicians of India. 2005 Apr; 53(): 298 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/84933 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Erythema --chemically induced | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hyperpigmentation --chemically induced | en_US |
dc.subject.mesh | Leukemia, Myelogenous, Chronic, BCR-ABL Positive --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Piperazines --adverse effects | en_US |
dc.subject.mesh | Protein Kinase Inhibitors --adverse effects | en_US |
dc.subject.mesh | Pyrimidines --adverse effects | en_US |
dc.title | Dermatological toxicity of imatinib mesylate. | en_US |
dc.type | Case Reports | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1